OmniStar Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.98M Buy
23,190
+1,804
+8% +$211K 1.37% 24
2026
Q1
$2.57M Buy
21,386
+2,512
+13% +$290K 1.33% 22
2025
Q4
$1.99M Buy
18,874
+1,434
+8% +$135K 1.16% 23
2025
Q3
$1.46M Buy
17,440
+3,566
+26% +$294K 0.89% 35
2025
Q2
$1.1M Buy
13,874
+3,296
+31% +$262K 0.82% 40
2025
Q1
$952K Buy
10,578
+5,666
+115% +$529K 0.75% 47
2024
Q4
$489K Sell
4,912
-1,731
-26% -$178K 0.39% 88
2024
Q3
$755K Buy
6,643
+1,539
+30% +$183K 0.57% 64
2024
Q2
$632K Sell
5,104
-454
-8% -$58.5K 0.57% 69
2024
Q1
$733K Sell
5,558
-2,588
-32% -$319K 0.67% 49
2023
Q4
$888K Buy
8,146
+1,105
+16% +$115K 1.11% 23
2023
Q3
$727K Sell
7,041
-68
-1% -$7.33K 0.86% 35
2023
Q2
$820K Sell
7,109
-5,085
-42% -$577K 0.96% 31
2023
Q1
$1.3M Sell
12,194
-1,354
-10% -$146K 1.65% 13
2022
Q4
$1.5M Sell
13,548
-355
-3% -$36.3K 1.71% 10
2022
Q3
$1.2M Buy
13,903
+2,544
+22% +$227K 1.43% 19
2022
Q2
$1.03M Buy
11,359
+22
+0.2% +$1.95K 1.15% 28
2022
Q1
$930K Buy
11,337
+947
+9% +$74.7K 0.92% 37
2021
Q4
$796K Buy
10,390
+1,029
+11% +$82K 0.81% 51
2021
Q3
$703K Buy
+9,361
New +$712K 0.83% 43
2021
Q2
Sell
-15,516
Closed -$1.15M 153
2021
Q1
$1.14M Sell
15,516
-12,292
-44% -$907K 1.45% 18
2020
Q4
$2.17M Sell
27,808
-12,161
-30% -$930K 1.52% 17
2020
Q3
$3.16M Sell
39,969
-459
-1% -$36K 2.39% 7
2020
Q2
$2.98M Buy
40,428
+10,397
+35% +$783K 2.46% 7
2020
Q1
$2.21M Buy
30,031
+6,753
+29% +$531K 2.17% 8
2019
Q4
$2.02M Sell
23,278
-947
-4% -$77.8K 1.7% 15
2019
Q3
$1.95M Sell
24,225
-58
-0.2% -$4.65K 1.7% 17
2019
Q2
$1.94M Buy
24,283
+4,652
+24% +$356K 1.74% 14
2019
Q1
$1.56M Buy
19,631
+788
+4% +$58.9K 1.37% 26
2018
Q4
$1.37M Buy
+18,843
New +$1.33M 1.4% 29
2018
Q3
Sell
-6,282
Closed -$363K 143
2018
Q2
$363K Buy
6,282
+624
+11% +$35.2K 0.35% 79
2018
Q1
$294K Sell
5,658
-295
-5% -$15.9K 0.28% 88
2017
Q4
$319K Buy
+5,953
New +$330K 0.29% 81

Other funds holding MRK

OmniStar Financial Group's MRK Position: Q2 2026 in Review

OmniStar Financial Group increased its Merck (MRK) stake by 8.4% in Q2 2026, buying an estimated $211K and bringing the position to 23,190 shares worth $2.98M. The position accounts for 1.37% of the portfolio, ranked #24.

OmniStar Financial Group first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. The position peaked at $3.16M in Q3 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • OmniStar Financial Group held 23,190 shares of Merck worth $2.98M as of Q2 2026.
  • OmniStar Financial Group bought 1,804 Merck shares in Q2 2026, an estimated $211K.
  • Merck made up 1.37% of OmniStar Financial Group's portfolio in Q2 2026, its #24 holding.
  • OmniStar Financial Group first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
  • OmniStar Financial Group's Merck position peaked at $3.16M in Q3 2020.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.